SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
LOPEZ GEORGE A
(Last) (First) (Middle)
951 CALLE AMANECER
(Street)
SAN CLEMENTE CA 92673
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) X Other (specify below)
Chairman Chairman
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2010
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/19/2010 05/19/2010 S 17 D $32.83 390,102 D
Common Stock 05/19/2010 05/19/2010 S 39 D $32.84 390,063 D
Common Stock 05/19/2010 05/19/2010 S 171 D $32.87 389,892 D
Common Stock 05/19/2010 05/19/2010 S 29 D $32.88 389,863 D
Common Stock 05/19/2010 05/19/2010 S 403 D $32.89 389,460 D
Common Stock 05/19/2010 05/19/2010 S 183 D $32.895 389,277 D
Common Stock 05/19/2010 05/19/2010 S 519 D $32.9 388,758 D
Common Stock 05/19/2010 05/19/2010 S 900 D $32.91 387,858 D
Common Stock 05/19/2010 05/19/2010 S 1,112 D $32.92 386,746 D
Common Stock 05/19/2010 05/19/2010 S 2,916 D $32.93 383,830 D
Common Stock 05/19/2010 05/19/2010 S 131 D $32.935 383,699 D
Common Stock 05/19/2010 05/19/2010 S 5,365 D $32.94 378,334 D
Common Stock 05/19/2010 05/19/2010 S 699 D $32.945 377,635 D
Common Stock 05/19/2010 05/19/2010 S 6,999 D $32.95 370,636 D
Common Stock 05/19/2010 05/19/2010 S 6,566 D $32.96 364,070 D
Common Stock 05/19/2010 05/19/2010 S 3,963 D $32.97 360,107 D
Common Stock 05/19/2010 05/19/2010 S 3,735 D $32.98 356,372 D
Common Stock 05/19/2010 05/19/2010 S 2,589 D $32.99 353,783 D
Common Stock 05/19/2010 05/19/2010 S 6,419 D $33 347,364 D
Common Stock 05/19/2010 05/19/2010 S 4,200 D $33.01 343,164 D
Common Stock 05/19/2010 05/19/2010 S 974 D $33.02 342,190 D
Common Stock 05/19/2010 05/19/2010 S 3,028 D $33.03 339,162 D
Common Stock 05/19/2010 05/19/2010 S 1,200 D $33.04 337,962 D
Common Stock 05/19/2010 05/19/2010 S 100 D $33.045 337,862 D
Common Stock 05/19/2010 05/19/2010 S 3,001 D $33.05 334,861 D
Common Stock 05/19/2010 05/19/2010 S 242 D $33.06 334,619 D
Common Stock 05/19/2010 05/19/2010 S 600 D $33.09 334,019 D
Common Stock 05/19/2010 05/19/2010 S 100 D $33.1 333,919 D
Common Stock 1,186,843 I by Partnership(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Common Stock owned by George A. Lopez M.D. Second Family Limited Partnership. Dr. Lopez holds a one-percent general partnership interest in the Partnership. As general partner, he has the power to vote and power to dispose of the 1,186,843 shares owned by the Partnership and may be deemed to be beneficial owner of such shares. The Partnership acquired the shares on 2/24/99 from Trusts for the benefit of the Lopez children, the Christopher George Lopez Children's Trust and the Nicholas George Lopez Children's Trust, which own a 99% limited partnership in the Partnership. Dr. Lopez is not trustee of and has no interest in the children's Trusts. Except to the extent of his undivided one percent general partnership interest in the assets of the Partnership, Dr. Lopez disclaims any beneficial ownership of the shares owned by the Partnership.
By: Lynn DeMartini For: George A. Lopez, M.D. 05/19/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.